CervoMed Q1 EPS $(0.41) Misses $(0.39) Estimate, Sales $2.35M Beat $1.35M Estimate
CervoMed Q1 EPS $(0.41) Misses $(0.39) Estimate, Sales $2.35M Beat $1.35M Estimate
CervoMed第一季度每股收益美元（0.41美元）未達到預期（0.39美元），銷售額235萬美元超過135萬美元的預期
CervoMed (NASDAQ:CRVO) reported quarterly losses of $(0.41) per share which missed the analyst consensus estimate of $(0.39) by 5.13 percent. This is a 78.97 percent increase over losses of $(1.95) per share from the same period last year. The company reported quarterly sales of $2.35 million which beat the analyst consensus estimate of $1.35 million by 73.85 percent.
CervoMed（納斯達克股票代碼：CRVO）公佈的季度虧損爲每股0.41美元，比分析師普遍預期的0.39美元（0.39美元）低5.13％。與去年同期每股虧損1.95美元（1.95）相比，增長了78.97％。該公司公佈的季度銷售額爲235萬美元，比分析師普遍預期的135萬美元高出73.85％。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。